Pictet Asset Management (UK)’s TG Therapeutics TGTX Stock Holding History

Pictet Asset Management (UK)’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$62.1M	Buy	1,601,224 +559,953	+54%	+$22M	0.07%	305
2021 Q1	$50.2M	Buy	1,041,271 +300,935	+41%	+$14.5M	0.06%	327
2020 Q4	$38.5M	Buy	740,336 +732,536	+9,391%	+$24.7M	0.05%	355
2020 Q3	$209K	Buy	+7,800	New	+$179K	﹤0.01%	1400
2016 Q3	–	Sell	-1,215,449	Closed	-$9.14M	–	851
2016 Q2	$9.14M	Buy	1,215,449 +1,073,049	+754%	+$8.72M	0.04%	447
2016 Q1	$1.19M	Hold	142,400	–	–	0.01%	747
2015 Q4	$1.7M	Buy	142,400 +1,700	+1%	+$21.5K	0.01%	743
2015 Q3	$1.42M	Buy	140,700 +71,300	+103%	+$1.06M	0.01%	756
2015 Q2	$1.21M	Buy	69,400 +20,100	+41%	+$318K	﹤0.01%	786
2015 Q1	$688K	Buy	+49,300	New	+$746K	﹤0.01%	819

Other funds holding TGTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Pictet Asset Management (UK)'s TGTX Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its TG Therapeutics (TGTX) stake by 54% in Q2 2021, buying an estimated $22M and bringing the position to 1,601,224 shares worth $62.1M. The position accounts for 0.07% of the portfolio, ranked #305.

Pictet Asset Management (UK) first reported a position in TGTX in Q1 2015 and has held it in 10 quarters since. 237 funds tracked by Wall St. Rank hold TGTX as of Q2 2021.

Pictet Asset Management (UK) held 1,601,224 shares of TG Therapeutics worth $62.1M as of Q2 2021.
Pictet Asset Management (UK) bought 559,953 TG Therapeutics shares in Q2 2021, an estimated $22M.
TG Therapeutics made up 0.07% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #305 holding.
Pictet Asset Management (UK) first reported a position in TG Therapeutics in Q1 2015 and has held it in 10 quarters since.
237 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.